Profil
Gerd Binnig is the founder and Chief Technology Officer at Definiens AG, which is founded in 1994.
He was a Principal at International Business Machines Corp.
from 1985 to 1986 and a Professor at Stanford University from 1987 to 1988.
Binnig received his undergraduate degree in 1973 and his doctorate in 1978 from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Aktive Positionen von Gerd Binnig
Unternehmen | Position | Beginn |
---|---|---|
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Gründer | 01.01.1994 |
Ehemalige bekannte Positionen von Gerd Binnig
Unternehmen | Position | Ende |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
IBM | Corporate Officer/Principal | 01.01.1986 |
Ausbildung von Gerd Binnig
Johann Wolfgang Goethe-Universität Frankfurt am Main | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IBM | Technology Services |
Private Unternehmen | 1 |
---|---|
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |